Phio Pharmaceuticals Corp

NASDAQ:PHIO  
0.66
-0.04 (-6.13%)
Earnings Announcements

Phio Pharmaceuticals Reports 2021 Year End Results

Published: 03/22/2022 21:16 GMT
Phio Pharmaceuticals Corp (PHIO) - Phio Pharmaceuticals Reports 2021 Year End Financial Results and Provides Business Update.
Phio Pharmaceuticals Corp- at December 31, 2021, Company Had Cash of $24.1 Million.
Phio Pharmaceuticals Corp- Expects Its Current Cash Will Be Sufficient to Fund Currently Planned Operations to Q2 of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.31

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.